Ceribell (CBLL) Short-term Investments (2025 - 2026)
Ceribell's (CBLL) quarterly Short-term Investments came in at $96.6 million in Q2 2026, down 29.64% on a YoY basis from $137.3 million in Q2 2025, and up 0.69% quarter-over-quarter from $95.9 million in Q1 2026.
Powered by 
Analysis
Ceribell (CBLL) Short-term Investments (2025 - 2026) Analysis & Trends
Ceribell (CBLL) has reported Short-term Investments for 2 consecutive years, with $96.6 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Short-term Investments fell 29.64% year-over-year to $96.6 million; the trailing twelve-month figure through Jun 2026 stood at $96.6 million (down 29.64% YoY), and the FY2025 full-year result was $118.8 million, changed N/A from the prior year.
- Short-term Investments advanced to $96.6 million in Q2 2026 per CBLL's latest filing, from $95.9 million in the prior quarter.
- Across five years, Short-term Investments topped out at $144.8 million in Q3 2025 and bottomed at $29.3 million in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 29.54 Bn | 27.44 Bn | 2.18 Bn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn |
| 3 | Heartflow | 4.04 Bn | 3.66 Bn | 53.19 Mn |
| 4 | Neogen | 2.59 Bn | 2.41 Bn | 107.80 Mn |
| 5 | Butterfly Network | 1.96 Bn | 1.84 Bn | 23.29 Mn |
| 6 | Ceribell | 928.74 Mn | 799.48 Mn | 25.94 Mn |
| 7 | QuidelOrtho | 866.04 Mn | 742.64 Mn | - |
| 8 | Varex Imaging | 779.06 Mn | 679.86 Mn | 76.70 Mn |
| 9 | Prenetics Global | 339.99 Mn | 280.94 Mn | 30.20 Mn |
| 10 | CapsoVision | 318.60 Mn | 309.52 Mn | 1.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 96.60 Mn |
| Mar 31, 2026 | 95.93 Mn |
| Dec 31, 2025 | 118.79 Mn |
| Sep 30, 2025 | 144.80 Mn |
| Jun 30, 2025 | 137.29 Mn |
| Mar 31, 2025 | 29.34 Mn |